Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachin Punatar

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
International Immunopharmacology|October 27, 2023
Low levels of CD26 on certain cellular subtypes of donor harvest is associated with better clinical outcomes post allogeneic stem cell transplantation through regulation of NF-κB pathway and pro-inflammatory cytokinesShruti Kandekar, Sachin Punatar, Navin Khattry, et al.
Cell Transplantation|April 18, 2022
Role of Curcumin in Reducing Toxicities Associated With Mucosal Injury Following Melphalan-Based Conditioning in Autologous Transplant SettingSachin Punatar, Kritika Katti, Deepan Rajamanickam, et al.
Cell Transplantation|January 23, 2024
<i>Withania Somnifera</i> Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia EffectSaurabh Kumar Gupta, Dievya Gohil, Mohd Bashar Momin, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian CohortSelma Zenia D'Silva, Anand Bodade, Shalaka Kadam, et al.
Journal of Ophthalmic & Vision Research|October 3, 2024
Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell TransplantationVijay Shetty, Priyanka Kashelkar, Sachin Punatar, et al.
Plos One|February 4, 2022
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, et al.
The Indian Journal of Medical Research|April 5, 2024
Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective studySwati Chugh, Goutam Panda, Smruti Mokal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 12, 2026
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India - Knowing the UnknownSumeet Mirgh, Athira Surendran, Sachin Punatar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCTSachin Punatar, Vinodhini Murugaiyan, Komal Kumbhalwar, et al.
Journal of Adolescent and Young Adult Oncology|October 22, 2020
Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in IndiaLingaraj Nayak, Hasmukh Jain, Avinash Bonda, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
International Immunopharmacology|October 27, 2023
Low levels of CD26 on certain cellular subtypes of donor harvest is associated with better clinical outcomes post allogeneic stem cell transplantation through regulation of NF-κB pathway and pro-inflammatory cytokinesShruti Kandekar, Sachin Punatar, Navin Khattry, et al.
Cell Transplantation|April 18, 2022
Role of Curcumin in Reducing Toxicities Associated With Mucosal Injury Following Melphalan-Based Conditioning in Autologous Transplant SettingSachin Punatar, Kritika Katti, Deepan Rajamanickam, et al.
Cell Transplantation|January 23, 2024
<i>Withania Somnifera</i> Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia EffectSaurabh Kumar Gupta, Dievya Gohil, Mohd Bashar Momin, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian CohortSelma Zenia D'Silva, Anand Bodade, Shalaka Kadam, et al.
Journal of Ophthalmic & Vision Research|October 3, 2024
Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell TransplantationVijay Shetty, Priyanka Kashelkar, Sachin Punatar, et al.
Plos One|February 4, 2022
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, et al.
The Indian Journal of Medical Research|April 5, 2024
Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective studySwati Chugh, Goutam Panda, Smruti Mokal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 12, 2026
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India - Knowing the UnknownSumeet Mirgh, Athira Surendran, Sachin Punatar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCTSachin Punatar, Vinodhini Murugaiyan, Komal Kumbhalwar, et al.
Journal of Adolescent and Young Adult Oncology|October 22, 2020
Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in IndiaLingaraj Nayak, Hasmukh Jain, Avinash Bonda, et al.
Pageof 7